큐리언트

115180KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

20,000KRWMarket close of 10/20 (Tue)

Up +3.63%+700KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)21,650KRWUp +8.25%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
19,550
High
20,000
Low
18,720
Day range
Day range low 18,720 high 20,000, open 19,550, close 20,000, previous close 19,300
Volume
11×10K shares
2.2B KRW 0.76× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 14,850 to 50,900 won, 14% up from the low

14% of the way up from the lowest close in 1 year (252 sessions) · -60.7% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-36.8B KRWOperating income over the last four quarters -36.8B KRW (loss)Operating income, 8 quarters
  • Daily moveusual range+3.63%+3.63%, 0.9× the usual (20-session average ±4.16%)
    That day +3.63% · usual ±4.16% · large-move threshold ±8.3%
  • Trading valueusual range0.8×2.2B KRW, 0.8× the 20-session average
    0.76× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+900.00 million KRWusual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 26 days
  • Next data 10/22 (Thu) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.